We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,678 results
  1. Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas

    Background

    Neutrophil extracellular traps (NETs) are extracellular chromatin structures composed of cytoplasmic, granular, and nuclear components of...

    Hiroyuki Yamamoto, Yoshitsugu Nakanishi, ... Satoshi Hirano in Annals of Surgical Oncology
    Article 05 December 2023
  2. Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

    Background

    Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective...

    Tao **a, Keyu Li, ... Lei Zheng in Journal of Hematology & Oncology
    Article Open access 28 March 2022
  3. Portal vein arterialization: a possibility in cholangiocarcinomas infiltrating the right hepatic artery?

    Portal vein arterialization (PVA) in advanced cholangiocarcinoma (CCA) is an emerging field of study too little explored despite its potential...

    Rebecca Marino, Francesca Ratti, ... Luca Aldrighetti in Updates in Surgery
    Article 23 May 2022
  4. Role of Intraoperative Frozen Section Assessment of Proximal Bile Duct Margins and the Impact of Additional Re-Resection in Perihilar Cholangiocarcinomas

    Intraoperative frozen section (FS) analysis to assess the bile duct margin status is commonly used to assess the completeness of resection during...

    Gurudutt P. Varty, Mahesh Goel, ... Shraddha Patkar in Indian Journal of Surgical Oncology
    Article 09 January 2024
  5. Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

    Background

    The results of the phase III ClarIDHy trial have led to US FDA approval of ivosidenib as a therapeutic option for patients with locally...

    Margherita Rimini, Valentina Burgio, ... Andrea Casadei-Gardini in Targeted Oncology
    Article 17 September 2022
  6. Multiple cholangiocarcinomas in the intrahepatic and extrahepatic biliary tree due to dichloromethane exposure: a case report

    Background

    An outbreak of cholangiocarcinoma in Japan has led to widespread concern among workers in printing plants. In March 2013, the Japanese...

    Daisuke Ogawa, Hiromitsu Hayashi, ... Hideo Baba in Surgical Case Reports
    Article Open access 21 April 2020
  7. Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors

    Purpose

    Everolimus (EVE) and sorafenib (SOR) combination was associated with synergistic activity in preclinical models. However, previous clinical...

    Romain Varnier, Alicja Puszkiel, ... Benoit You in Cancer Chemotherapy and Pharmacology
    Article 25 February 2023
  8. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas

    Background

    The differences between perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC) regarding recurrence and the factors that...

    Yoshitsugu Nakanishi, Keisuke Okamura, ... Satoshi Hirano in Annals of Surgical Oncology
    Article 03 May 2020
  9. Approach to Resectable Biliary Cancers

    Biliary malignancies, although rare, can be some of the most challenging to manage surgically. Intrahepatic cholangiocarcinomas are resectable if...

    Kimberly Washington, Flavio Rocha in Current Treatment Options in Oncology
    Article 15 September 2021
  10. Intraductal papillary neoplasm of the bile duct with metachronous development in the downstream bile duct after radical resection

    We report a case of intraductal papillary neoplasms of the bile duct (IPNB) that metachronously developed twice in the downstream bile duct after...

    Taito Ito, Takeshi Hisa, ... Satoshi Shiozawa in Clinical Journal of Gastroenterology
    Article 14 October 2023
  11. Postoperative Prognosis According to Pathologic Categorization of Desmoplastic Reaction in Patients with Extrahepatic Cholangiocarcinoma

    Background

    Recent studies have demonstrated the importance of desmoplastic reaction (DR) in predicting postoperative prognosis for patients with...

    Yusuke Yoshida, Yoshitsugu Nakanishi, ... Satoshi Hirano in Annals of Surgical Oncology
    Article 01 August 2023
  12. Applications of artificial intelligence in biliary tract cancers

    Biliary tract cancers are malignant neoplasms arising from bile duct epithelial cells. They include cholangiocarcinomas and gallbladder cancer....

    Pankaj Gupta, Soumen Basu, Chetan Arora in Indian Journal of Gastroenterology
    Article 01 March 2024
  13. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma

    Background

    The differential diagnosis of intrahepatic cholangiocarcinomas (iCCAs) from metastatic adenocarcinomas from organs adjacent to the liver...

    Yeon Seung Chung, Youngsic Jeon, ... Young Nyun Park in Hepatology International
    Article 17 October 2022
  14. Immunotherapy in Biliary Tract Cancers: Where Are We?

    Purpose of Review

    Biliary tract cancers (BTCs) are a heterogenous group of cancers arising from the biliary tract. The hallmark of these cancers is...

    Aparna Kalyan, Harshit Khosla, Richard D. Kim in Current Oncology Reports
    Article 04 October 2022
  15. Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma

    The mutant IDH1 inhibitor ivosidenib improves outcomes for patients with IDH1- mutated cholangiocarcinoma, but resistance inevitably develops....

    James M. Cleary, Betty Rouaisnel, ... Julie-Aurore Losman in npj Precision Oncology
    Article Open access 02 September 2022
  16. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas

    Objectives

    To identify imaging features that assist in discriminating intraductal papillary neoplasms of the bile duct (IPNBs) from papillary...

    Takahiro Komori, Dai Inoue, ... Toshifumi Gabata in European Radiology
    Article 05 December 2018
  17. Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas

    Biliary tract carcinomas are divided into intrahepatic, perihilar, distal extrahepatic cholangiocarcinomas, and gallbladder adenocarcinomas....

    Jeremy Augustin, Caroline Gabignon, ... Dominique Wendum in Virchows Archiv
    Article 24 May 2020
  18. Rolle der Resektion und Transplantation beim Cholangiokarzinom

    Surgical resection represents the backbone of a curative therapeutic approach for cholangiocarcinomas. Precise understanding of the individual...

    Nora Nevermann, Florian W. R. Vondran, Moritz Schmelzle in Die Onkologie
    Article 06 July 2023
Did you find what you were looking for? Share feedback.